Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.04 Insider Own63.86% Shs Outstand35.62M Perf Week3.23%
Market Cap114.78M Forward P/E- EPS next Y-2.35 Insider Trans0.02% Shs Float12.96M Perf Month-54.02%
Income-78.92M PEG- EPS next Q-0.54 Inst Own35.32% Short Float / Ratio6.25% / 9.48 Perf Quarter-47.88%
Sales0.00M P/S- EPS this Y2.49% Inst Trans30.14% Short Interest0.81M Perf Half Y-68.00%
Book/sh3.79 P/B0.85 EPS next Y-11.75% ROA-42.13% Target Price19.88 Perf Year-74.40%
Cash/sh3.73 P/C0.86 EPS next 5Y- ROE-46.19% 52W Range2.85 - 13.10 Perf YTD-74.40%
Dividend- P/FCF- EPS past 5Y- ROI-52.96% 52W High-75.57% Beta1.75
Dividend %- Quick Ratio13.79 Sales past 5Y0.00% Gross Margin- 52W Low12.28% ATR0.63
Employees56 Current Ratio13.79 Sales Q/Q- Oper. Margin0.00% RSI (14)32.28 Volatility10.94% 12.92%
OptionableNo Debt/Eq0.10 EPS Q/Q-0.49% Profit Margin- Rel Volume3.91 Prev Close3.18
ShortableYes LT Debt/Eq0.10 EarningsNov 07 BMO Payout- Avg Volume85.50K Price3.20
Recom1.25 SMA20-35.68% SMA50-45.60% SMA200-60.60% Volume334,425 Change0.63%
Date Action Analyst Rating Change Price Target Change
Oct-18-23Initiated JMP Securities Mkt Outperform $23
Mar-31-23Initiated Mizuho Buy $15
Sep-16-22Initiated Wedbush Outperform $19
Aug-29-22Initiated H.C. Wainwright Buy $24
Feb-01-22Initiated Stifel Buy $24
Feb-01-22Initiated Morgan Stanley Equal-Weight $17
Feb-01-22Initiated Jefferies Buy $20
Feb-01-22Initiated Guggenheim Buy $23
Nov-22-23 04:05PM
Nov-16-23 04:05PM
Nov-07-23 07:05AM
Oct-18-23 09:52AM
Oct-17-23 07:05AM
04:01PM Loading…
Oct-05-23 04:01PM
Sep-26-23 07:05AM
Sep-11-23 12:00PM
Sep-08-23 04:05PM
Aug-08-23 07:05AM
Aug-07-23 04:05PM
Jun-01-23 07:00AM
May-10-23 07:00AM
May-09-23 07:00AM
08:30AM Loading…
May-08-23 08:30AM
Mar-30-23 07:00AM
Mar-22-23 07:00AM
Mar-21-23 07:00AM
Mar-02-23 04:00PM
Jan-03-23 07:00AM
Dec-15-22 04:01PM
Dec-14-22 04:01PM
Nov-29-22 05:23AM
Nov-28-22 07:00AM
Nov-10-22 07:00AM
Nov-07-22 07:00AM
Nov-02-22 12:43PM
07:00AM Loading…
Nov-01-22 07:00AM
Oct-12-22 07:58AM
Sep-14-22 09:55AM
Sep-01-22 07:00AM
Aug-29-22 09:55AM
Aug-12-22 09:55AM
Aug-08-22 07:00AM
Aug-02-22 07:00AM
Aug-01-22 07:00AM
Jul-28-22 07:00AM
Jun-09-22 09:58AM
Jun-07-22 07:00AM
Jun-01-22 07:00AM
May-12-22 07:00AM
Apr-20-22 07:00AM
Apr-08-22 12:33PM
Mar-25-22 06:30AM
Mar-21-22 07:00AM
Mar-03-22 04:05PM
Jan-27-22 01:46PM
Jan-11-22 04:01PM
Jan-06-22 11:07PM
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Magovcevic-Liebisch IvanaPresident and CEONov 20Buy3.754,00015,000207,687Nov 20 06:34 PM